Bridget Puffer

Title: The Innovative Contributions of Bridget Puffer

Introduction

Bridget Puffer, an accomplished inventor based in Corning, NY, has made significant contributions to the field of biotechnology. With six patents to her name, her work primarily focuses on innovative solutions pertaining to infectious diseases, particularly those affecting equines.

Latest Patents

Bridget's latest patents include the development of a novel Flavivirus reporter virus and methods for its production and use. This invention revolves around the production of flavivirus replicons, flavivirus particles, and reporter virus particles, as well as chimeric and codon-optimized variants. Additionally, she has introduced an Equine Infectious Anemia (EIA) vaccine that offers immunity to mammals, especially horses, from the EIA virus. This vaccine features specific mutations that prevent the vaccine strain from causing clinical disease and allows for differentiation between vaccinated and non-vaccinated animals exposed to the virus.

Career Highlights

Throughout her career, Bridget has held positions with notable companies such as Akzo Nobel N.V. and Integral Molecular, Inc. Her work in these organizations has been instrumental in advancing research in infectious diseases and developing effective vaccines.

Collaborations

Bridget has collaborated with esteemed colleagues like Ronald C. Montelaro and Charles Issel, contributing to a robust exchange of ideas and research in her field. These partnerships have facilitated innovative approaches to tackling challenges posed by infectious agents.

Conclusion

Bridget Puffer stands out as a dedicated inventor whose work has significantly impacted the biotechnology sector. Her innovative patents reflect a commitment to advancing medical science and improving animal health, reinforcing her importance in the field. As her career continues, Bridget's contributions are sure to pave the way for further innovations in disease prevention and treatment.